Signals of infected pancreatic necrosis from blood
Part of Digestive system clinical trials.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of necrotizing pancreatitis (a serious infection of the pancreas) confirmed by a special CT scan.
- You cannot have had repeated attacks of acute pancreatitis (sudden pancreas inflammation).
- You cannot have pancreatic cancer.
- You cannot be pregnant or breastfeeding.
- You cannot have had a solid organ transplant (like a kidney or liver transplant).
- You cannot have an immune deficiency disorder such as AIDS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This trial is testing a device that filters your blood to remove inflammatory particles (cfDNA and NETs) that may be worsening organ damage from pancreatitis. It is for people who have developed breathing, heart, or kidney problems while hospitalized with pancreatitis.
This trial uses a blood test to look for infection in people with a severe type of pancreatitis (inflammation of the pancreas). The goal is to see if the test can find infections faster and more accurately than current methods.
This trial looks at whether routine blood test results can help doctors predict how severe acute pancreatitis will be and how well patients may recover. It aims to find simple, early clues to guide treatment.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.